U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula C16H12ClNOS
Molecular Weight 301.791
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HMR-1426

SMILES

OC12N=C(SC1CC3=C2C=CC(Cl)=C3)C4=CC=CC=C4

InChI

InChIKey=RUBKYBIDEVUTQU-UHFFFAOYSA-N
InChI=1S/C16H12ClNOS/c17-12-6-7-13-11(8-12)9-14-16(13,19)18-15(20-14)10-4-2-1-3-5-10/h1-8,14,19H,9H2

HIDE SMILES / InChI

Molecular Formula C16H12ClNOS
Molecular Weight 301.791
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 18:34:44 GMT 2025
Edited
by admin
on Mon Mar 31 18:34:44 GMT 2025
Record UNII
BD22Q5WK25
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HMR-1426
Code English
HMR1426
Preferred Name English
3AH-INDENO(1,2-D)THIAZOL-3A-OL, 6-CHLORO-8,8A-DIHYDRO-2-PHENYL-
Systematic Name English
6-CHLORO-2-PHENYL-3A,4-DIHYDROINDENO(1,2-D)THIAZOL-8B-OL
Systematic Name English
Code System Code Type Description
CAS
262376-75-0
Created by admin on Mon Mar 31 18:34:44 GMT 2025 , Edited by admin on Mon Mar 31 18:34:44 GMT 2025
PRIMARY
FDA UNII
BD22Q5WK25
Created by admin on Mon Mar 31 18:34:44 GMT 2025 , Edited by admin on Mon Mar 31 18:34:44 GMT 2025
PRIMARY
CAS
782482-03-5
Created by admin on Mon Mar 31 18:34:44 GMT 2025 , Edited by admin on Mon Mar 31 18:34:44 GMT 2025
SUPERSEDED
EPA CompTox
DTXSID9047338
Created by admin on Mon Mar 31 18:34:44 GMT 2025 , Edited by admin on Mon Mar 31 18:34:44 GMT 2025
PRIMARY
PUBCHEM
9882837
Created by admin on Mon Mar 31 18:34:44 GMT 2025 , Edited by admin on Mon Mar 31 18:34:44 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY
HMR1426 inhibited feed consumption dose-dependently in rodents. We proved that HMR1426 is not a CCK(A) agonist. The correlation between anorectic properties of HMR1426 and gastric emptying suggests that gastric emptying may cause the anorectic properties of HMR1426. The differences in microstructural feeding behavior between HMR1426 and centrally active anorectics makes it unlikely that HMR1426 acts via the CNS.
ACTIVE MOIETY
HMR1426 (50 mg/kg) caused an acute and chronic decrease of food intake. There was no effect on the level and daily pattern of total energy expenditure, Tb, and locomotor activity.